Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects.

Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu X, McCaul ME.

Addict Biol. 2013 Jan;18(1):181-92. doi: 10.1111/j.1369-1600.2011.00430.x. Epub 2012 Jan 20.

2.

The relationship between naloxone-induced cortisol and mu opioid receptor availability in mesolimbic structures is disrupted in alcohol dependent subjects.

Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu X, McCaul ME.

Alcohol. 2012 Sep;46(6):511-7. doi: 10.1016/j.alcohol.2012.04.006. Epub 2012 Jun 18.

3.

Naloxone-induced cortisol predicts mu opioid receptor binding potential in specific brain regions of healthy subjects.

Wand GS, Weerts EM, Kuwabara H, Frost JJ, Xu X, McCaul ME.

Psychoneuroendocrinology. 2011 Nov;36(10):1453-9. doi: 10.1016/j.psyneuen.2011.03.019. Epub 2011 May 6.

4.

Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.

Weerts EM, Wand GS, Kuwabara H, Munro CA, Dannals RF, Hilton J, Frost JJ, McCaul ME.

Alcohol Clin Exp Res. 2011 Dec;35(12):2162-73. doi: 10.1111/j.1530-0277.2011.01565.x. Epub 2011 Jun 20.

5.

The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.

Inder WJ, Joyce PR, Ellis MJ, Evans MJ, Livesey JH, Donald RA.

Clin Endocrinol (Oxf). 1995 Sep;43(3):283-90.

PMID:
7586596
6.

Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys.

Williams KL, Ko MC, Rice KC, Woods JH.

Psychoneuroendocrinology. 2003 May;28(4):513-28.

PMID:
12689609
7.

Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism.

Schluger JH, Ho A, Borg L, Porter M, Maniar S, Gunduz M, Perret G, King A, Kreek MJ.

Alcohol Clin Exp Res. 1998 Oct;22(7):1430-6.

PMID:
9802524
8.
9.

Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects.

Weerts EM, Kim YK, Wand GS, Dannals RF, Lee JS, Frost JJ, McCaul ME.

Neuropsychopharmacology. 2008 Feb;33(3):653-65. Epub 2007 May 9.

10.

Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.

Scott LV, Burnett F, Medbak S, Dinan TG.

Psychol Med. 1998 Mar;28(2):285-93.

PMID:
9572086
11.

Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study.

Spreckelmeyer KN, Paulzen M, Raptis M, Baltus T, Schaffrath S, Van Waesberghe J, Zalewski MM, Rösch F, Vernaleken I, Schäfer WM, Gründer G.

Biol Psychiatry. 2011 Oct 15;70(8):770-6. doi: 10.1016/j.biopsych.2011.05.035. Epub 2011 Jul 29.

PMID:
21802658
12.
13.

The effect of naloxone on adrenocorticotropin and cortisol release: evidence for a reduced response in depression.

Burnett FE, Scott LV, Weaver MG, Medbak SH, Dinan TG.

J Affect Disord. 1999 Jun;53(3):263-8.

PMID:
10404712
14.

Acute HPA axis response to naltrexone differs in female vs. male smokers.

Roche DJ, Childs E, Epstein AM, King AC.

Psychoneuroendocrinology. 2010 May;35(4):596-606. doi: 10.1016/j.psyneuen.2009.09.016. Epub 2009 Oct 17.

15.
16.

Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene.

Geer EB, Landman RE, Wardlaw SL, Conwell IM, Freda PU.

Pituitary. 2005;8(2):115-22.

PMID:
16379031
17.

Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.

Lanzone A, Guido M, Ciampelli M, Fulghesu AM, Pavone V, Proto C, Caruso A, Mancuso S.

Clin Endocrinol (Oxf). 1996 Jul;45(1):73-7.

PMID:
8796141
19.

Comparison of HPA axis hormonal responses to naloxone vs psychologically-induced stress.

Oswald LM, Mathena JR, Wand GS.

Psychoneuroendocrinology. 2004 Apr;29(3):371-88.

PMID:
14644067
20.

The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress.

Chong RY, Oswald L, Yang X, Uhart M, Lin PI, Wand GS.

Neuropsychopharmacology. 2006 Jan;31(1):204-11.

Supplemental Content

Support Center